1. Home
  2. YELP vs EVO Comparison

YELP vs EVO Comparison

Compare YELP & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yelp Inc.

YELP

Yelp Inc.

HOLD

Current Price

$25.79

Market Cap

1.2B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.00

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YELP
EVO
Founded
2004
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
YELP
EVO
Price
$25.79
$2.00
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$29.17
$7.00
AVG Volume (30 Days)
1.3M
39.3K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
19.15
N/A
EPS
0.30
N/A
Revenue
$1,464,955,000.00
N/A
Revenue This Year
$2.19
$1.37
Revenue Next Year
$2.34
$10.05
P/E Ratio
$87.77
N/A
Revenue Growth
3.75
N/A
52 Week Low
$19.60
$1.95
52 Week High
$35.26
$4.42

Technical Indicators

Market Signals
Indicator
YELP
EVO
Relative Strength Index (RSI) 53.26 25.09
Support Level $23.85 N/A
Resistance Level $27.23 $3.36
Average True Range (ATR) 1.04 0.10
MACD 0.02 -0.08
Stochastic Oscillator 40.66 5.10

Price Performance

Historical Comparison
YELP
EVO

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: